ARCUTIS BIOTHERAPEUTIC
11.51
26-November-24 16:45:00
15 minutes delayed
Stocks
+0.74
+6.87%
Today's range
10.57 - 11.64
ISIN
N/A
Source
NASDAQ
-
Arcutis to Present at the TD Cowen 44th Annual Health Care Conference
29 Feb 2024 17:00:33 By Nasdaq GlobeNewswire
-
Arcutis Announces Pricing of $150 Million Public Offering
28 Feb 2024 23:30:21 By Nasdaq GlobeNewswire
-
Arcutis Announces Proposed Public Offering
28 Feb 2024 16:10:00 By Nasdaq GlobeNewswire
-
28 Feb 2024 16:00:00 By Nasdaq GlobeNewswire
-
Arcutis Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
27 Feb 2024 05:50:12 By Nasdaq GlobeNewswire
-
Arcutis to Report Fourth Quarter and Full Year 2023 Financial Results
16 Feb 2024 08:00:00 By Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 Feb 2024 16:00:00 By Nasdaq GlobeNewswire
-
Arcutis to Present at the Guggenheim Healthcare Talks – 6th Annual Biotechnology Conference
31 Jan 2024 08:00:00 By Nasdaq GlobeNewswire
-
29 Jan 2024 08:00:00 By Nasdaq GlobeNewswire
-
22 Jan 2024 08:00:00 By Nasdaq GlobeNewswire
-
14 Jan 2024 04:00:00 By Nasdaq GlobeNewswire
-
14 Jan 2024 04:00:00 By Nasdaq GlobeNewswire
-
15 Dec 2023 17:11:43 By Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Dec 2023 22:00:49 By Nasdaq GlobeNewswire
-
29 Nov 2023 08:00:00 By Nasdaq GlobeNewswire
-
Arcutis Announces Third Quarter 2023 Financial Results and Provides Business Update
03 Nov 2023 07:30:00 By Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 Nov 2023 16:00:00 By Nasdaq GlobeNewswire
-
Arcutis to Report Third Quarter 2023 Financial Results
25 Oct 2023 16:00:00 By Nasdaq GlobeNewswire
-
20 Oct 2023 08:00:00 By Nasdaq GlobeNewswire